News
Press Releases
2018/11/28
WuXi AppTec Receives 2018 Global Integrated Drug R&D Services Competitive Strategy Innovation & Leadership Award from Frost & Sullivan
SHANGHAI, Nov. 28, 2018 -- WuXi AppTec, a leading global pharmaceutical, biotechnology and medical device open-access capability and technology platform, today announced that it received the 2018 Global Integrated Drug R&D Services Competitive Strategy Innovation & Leadership Award from Frost & Sullivan, a top-notch business research and consulting firm. WuXi was awarded for the second consecutive year.
Read more2018/11/16
WuXi AppTec Opens Its New Medical Device Testing Center in Suzhou
WuXi AppTec announces today that its Laboratory Testing Division’s new Medical Device Testing Center opens today in Suzhou, China.
Read more2018/09/06
WuXi AppTec Partner Hutchison MediPharma Receives Approval of Fruquintinib Capsules in China
SHANGHAI, Sep 6, 2018: WuXi AppTec congratulates its partner Hutchison MediPharma (HMP) on receiving approval of fruquintinib capsules (Elunate®) for metastatic colorectal cancer from the National Medical Products Administration of China (“NMPA”) – formerly the China Food and Drug Administration. Fruquintinib is an innovative medicine that has not previously been launched in China or internationally.
Read more2018/08/22
WuXi AppTec Appoints Edward Hu as Co-CEO
SHANGHAI, August 22, 2018 /PRNewswire/-- WuXi AppTec (603259.SH), a leading global pharmaceutical and medical device open-access capability and technology platform company, today announces the appointment of Mr. Edward Hu as Co-CEO of the company. Mr. Hu will continue to report to Dr. Ge Li, Chairman and CEO of WuXi AppTec.
Read more2018/07/26
WuXi STA’s Jinshan Site Passes Fourth U.S. FDA Inspection
SHANGHAI, July 26, 2018: STA Pharmaceutical Co., Ltd., (WuXi STA), a subsidiary of WuXi AppTec, announces that its Active Pharmaceutical Ingredient (API) manufacturing facility at Jinshan (Shanghai, China) has successfully passed its fourth inspection from the U.S. Food and Drug Administration (USFDA) – with no Form 483s issued. The site previously passed three FDA inspections in 2013, 2014 and 2016.
Read more